Catalyst Health Ventures

We focus on investment opportunities within the healthcare and life science markets where we can identify value early. We work actively with founders and entrepreneurs, providing guidance, support, and access to our network. We strongly believe that no two investments are the same and support the most suitable business model for each individual venture, working with management teams to formulate strategies to achieve financial independence. We are comfortable financing companies by ourselves, and if appropriate, work closely with the founders to help build a syndicate of co-investors who bring complementary relationships and share our vision. Our investment strategy is optimized for effective early-stage healthcare investing and has produced a track record of success. We carefully select and build our portfolio based on four key criteria. 1) Global Market Opportunities We seek to invest in companies addressing major global unmet clinical needs in areas such as oncology, cardiovascular disease, obesity, and women’s health. We invest in pioneering and proprietary technological solutions fundamentally designed to reduce treatment costs and improve patient outcomes. 2) Risk Minimization By investing in solutions that have a technological foundation of engineering and development such as medical devices, diagnostic tools and instrumentation, and consumer healthcare, we minimize the risks related to uncertain scientific experimentation. 3) Capital Efficiency We are passionately dedicated to utilizing our capital in a highly efficient manner to help meet the goals of both our portfolio companies and our limited partners. By focusing our investments in companies that are capable of generating substantial value on smaller amounts of capital, we preserve the opportunity for outsized returns in diverse market conditions. 4) Building long-term partnerships We are patient, long term investors supporting our companies throughout their life cycle. We invest early and keep investing as value is created and risk reduced. Recognizing that no two companies are the same, we listen and work with management teams to determine our portfolio companies’ total capital needs, from inception to exit.